VTA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.161400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.226800E-01
Normal-vs-Stage2
5.390400E-01
Normal-vs-Stage3
1.540400E-01
Normal-vs-Stage4
8.743600E-01
Stage1-vs-Stage2
6.994200E-01
Stage1-vs-Stage3
5.116200E-01
Stage1-vs-Stage4
4.100800E-01
Stage2-vs-Stage3
1.993160E-01
Stage2-vs-Stage4
3.655000E-01
Stage3-vs-Stage4
1.211410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.683000E-01
Normal-vs-AfricanAmerican
8.456200E-01
Normal-vs-Asian
5.188800E-01
Caucasian-vs-AfricanAmerican
1.847780E-01
Caucasian-vs-Asian
8.531200E-01
AfricanAmerican-vs-Asian
3.001800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.764000E-01
Normal-vs-Female
5.870400E-01
Male-vs-Female
4.858200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.880400E-01
Normal-vs-Age(41-60Yrs)
8.595000E-01
Normal-vs-Age(61-80Yrs)
3.861800E-01
Normal-vs-Age(81-100Yrs)
6.793400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.894010E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.355400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.957000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.776600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.827200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.962000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.019000E-01
Normal-vs-Daily Drinker
1.983810E-01
Normal-vs-Weekly Drinker
2.793800E-01
Normal-vs-Occasional Drinker
8.393400E-01
Normal-vs-Social Drinker
5.520800E-01
Non Drinker-vs-Daily Drinker
4.881600E-01
Non Drinker-vs-Weekly Drinker
7.218400E-01
Non Drinker-vs-Occasional Drinker
1.723770E-02
Non Drinker-vs-Social Drinker
4.778800E-01
Daily Drinker-vs-Weekly Drinker
8.246600E-01
Daily Drinker-vs-Occasional Drinker
6.424300E-03
Daily Drinker-vs-Social Drinker
2.254600E-01
Weekly Drinker-vs-Occasional Drinker
2.824100E-02
Weekly Drinker-vs-Social Drinker
3.854600E-01
Occasional Drinker-vs-Social Drinker
1.659580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.192000E-01
Normal-vs-Grade 2
4.952000E-02
Normal-vs-Grade 3
7.735800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.311600E-01
Grade 1-vs-Grade 3
1.834560E-01
Grade 1-vs-Grade 4
2.192000E-01
Grade 2-vs-Grade 3
3.339400E-01
Grade 2-vs-Grade 4
4.952000E-02
Grade 3-vs-Grade 4
7.735800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.994400E-01
Normal-vs-NonDiabetic
4.107600E-01
Diabetic-vs-NonDiabetic
3.659200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.246100E-02
Normal-vs-NoPancreatitis
4.421400E-01
Pancreatitis-vs-NoPancreatitis
1.001830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.289400E-01
Normal-vs-N1
5.423400E-01
N0-vs-N1
7.896400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.633800E-01
Normal-vs-TP53-NonMutant
6.387400E-01
TP53-Mutant-vs-TP53-NonMutant
2.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
